Reducing Activities: company scaling back some business operations while continuing others
Stay Scaling Back
PAREXEL International is a global provider of biopharmaceutical services. It conducts clinical trials on behalf of its pharmaceutical clients to expedite the drug approval process. It is the second largest clinical research organization in the world and has helped develop approximately 95% of the 200 top-selling biopharmaceuticals on the market today.
Reducing Activities: company scaling back some business operations while continuing others
Stay Scaling BackPAREXEL have 6,000+ staff, with 30+ offices across the region, early phase clinics located in Berlin and London, and clinical trial supplies and logistics depots located in Germany and Russia.
Received revenues in Russia in 2021-2024, there is no any official announcement. Revenue decreased in 2024 vs 2023 by more than -20%.